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The world’s neglected tropical diseases (NTDs; Table 1) are becoming less neglected. Many millions of dollars and drugs are now committed to their control, and an 
open-access journal dedicated to NTDs, PLoS Neglected Tropical 
Diseases, has been launched (http://www.plosntds.org/). 
NTDs are characterised by their prevalence in rural areas of 
low-income countries and fragile states, their tendency to 
promote poverty, and the absence of commercial markets for 
tools that would control them, even though such tools exist 
and their success has been demonstrated [1]. 
NTD programmes are effective development investments 
because interventions can be delivered for less than $US1 per 
person per year and economic rates of return are 15%–30% 
[2]. In addition, individual NTD programmes are often 
able to share activities such as drug distribution because of 
geographical overlap between their target populations [1,3,4]. 
These beneﬁ ts were cited in the World Health Assembly 
resolution WHA 54.19, which recommends the provision of 
essential drugs against schistosomiasis and soil-transmitted 
helminthiasis for 100% of school children at risk by 2010 [5].
NTD programmes need to be able to demonstrate that they 
have met their objectives [6]. In general, each programme 
has established its own monitoring and evaluation system, 
such as microscopic counting of eggs in urine or faeces 
for schistosomiasis or hookworm, night blood ﬁ lms for 
microﬁ laria, or skin snips for onchocerciasis. Apart from 
the difﬁ culties of obtaining samples and transporting them 
to a laboratory or setting up microscopy services within 
communities, the high day-to-day variability of biological 
measurements within individuals makes such methods of 
monitoring tedious and insufﬁ cient on their own. These 
indicators evaluate infection rather than morbidity [6], and 
David Molyneux and colleagues have suggested that well-
being and equity would be more appropriate indicators to 
evaluate changes in public health [1].
Prevalence of anaemia could be added to this choice of 
indicators because: (1) such prevalence is objective and 
quantiﬁ able; (2) anaemia is a major complication of several 
NTDs; (3) it can be measured even in the most remote areas; 
and (4) it changes in a predictable fashion with alterations in 
disease burden. Because the prevalence of anaemia increases 
with worsening socio-economic status [7], it can be used 
to assess whether an intervention has reached the poorest 
communities in areas where NTDs are a major cause of 
anaemia.
Usefulness of Anaemia as an Indicator for NTDs
In developing countries, over half of all children and 
pregnant women are anaemic [8]. Even mild anaemia 
negatively affects health, productivity, development, and 
immune function, and it is particularly detrimental to 
children, pregnant women, and individuals with HIV 
infection [9]. The aetiology of anaemia is multifactorial 
in developing countries and includes deﬁ ciencies 
of micronutrients (e.g., iron, folate, vitamin B12); 
haemoglobinopathies; infections and chronic diseases 
(e.g., malaria, NTDs, HIV, tuberculosis); and cancer. Mean 
haemoglobin levels and/or the prevalence of anaemia will 
only be useful indicators for NTD programmes if they reﬂ ect 
changes in the burden of NTDs in the target populations in 
response to speciﬁ c interventions.
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Figure 1. Haemoglobin Colour Scale 
The colour of a ﬁ nger prick blood sample, soaked into chromatography 
paper, is compared with the colour of blood of known haemoglobin 
content depicted on the scale in 2 g/dl increments from 4 g/dl to 14 g/dl.
The Neglected Diseases section focuses attention either on a speciﬁ c disease or 
describes a novel strategy for approaching neglected health issues in general.
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Relationship between NTDs and Anaemia
Many NTDs cause anaemia either directly through blood 
loss or indirectly through bone marrow suppression, 
inﬂ ammation, hypersplenism, haemolysis, or anorexia [8,10]. 
Anaemia is particularly common in individuals infected with 
soil-transmitted helminths or schistosoma. The amount of 
blood loss in hookworm infections (Necator americanus and 
Ancylostoma duodenale) is strongly and linearly correlated with 
worm load and faecal egg count, and even light infections 
contribute signiﬁ cantly to anaemia [11]. Trichuris trichiura 
also causes intestinal blood loss, and schoolchildren with 
heavy T. trichiura infections have a higher prevalence of 
anaemia (haemoglobin [Hb] <11 g/dl) than uninfected 
controls [12].
Where transmission in communities is high, NTDs are a 
major cause of mild and moderate anaemia (i.e., Hb 7–11.9 
g/dl). For example, 66% of pregnant Tanzanian women [13] 
and 50%–62% of Tanzanian children [14,15] living in high-
risk areas for helminth and/or schistosomiasis infections have 
anaemia. Schistosoma mansoni, S. japonicum, and S. haematobium 
cause intestinal or urinary blood loss. Studies from Kenya, 
Niger, Tanzania, and elsewhere have shown that, despite 
the presence of confounding factors, haemoglobin levels of 
children and pregnant women correlate negatively with egg 
count in both S. mansoni and S. haematobium [9,14]. Infection 
with several parasites at once (“polyparasitism”) is common in 
tropical countries, particularly in poor communities. There 
is an inverse relationship between the number of parasites 
in an infected person and their Hb level. For example, low-
intensity polyparasite infections in children in the Philippines 
are associated with 5-fold increases in prevalence of anaemia 
(Hb <11 g/dl) [16]. Moderate/high intensity infections with 
three or four soil-transmitted helminths and S. japonicum are 
associated with 8-fold increases in anaemia.
In addition to its use in individual NTD programmes, 
anaemia monitoring could also be a useful tool when NTD 
control is integrated with other major diseases. Anaemia is 
a major cause of morbidity in co-infections with NTDs and 
malaria, HIV, and/or tuberculosis [2]. Up to 35% of anaemia 
cases in African children are due to malaria [17]. Anaemia is 
an independent prognostic marker in HIV infection; it also 
contributes to progression of both HIV and tuberculosis [18], 
and in some cases reversal of anaemia can reduce the risk of 
premature death from complications of HIV [18,19].
Effects of Programmes to Control NTDs on Anaemia 
Prevalence
Providing chemotherapy for groups at high risk of soil-
transmitted helminths improves growth and iron stores in 
children and reduces anaemia in pregnant women [20]. 
The impact of treatment on anaemia is well established 
for hookworm infections but seems to be less marked for 
trichuriasis, particularly outside Africa [21–23]. The effect 
of treatment for schistosomiasis on haemoglobin levels and 
prevalence of anaemia is difﬁ cult to disentangle from the 
confounding effects of other conditions causing anaemia, 
but overall schistosomiasis treatment alone appears to be 
beneﬁ cial for reducing the prevalence of anaemia [8].
Reduction in the prevalence of anaemia is used as a 
measurable target in programmes to reduce morbidity due 
to schistosomiasis and helminthiasis (see examples in Table 
2 and relationship between NTDs and anaemia in Table 3) 
[4,6,24]. Such a target is used because it reﬂ ects the aim of 
the programmes to reduce disease morbidity rather than 
transmission [4,20]. In integrated programmes that used 
control measures for more than one NTD, a combination of 
albendazole and praziquantel signiﬁ cantly reduced anaemia 
(deﬁ ned as Hb <12 g/dl) in Tanzanian children living in an 
area of high endemicity for helminth and schistosomiasis 
infections [25]. In Uganda, the same drug combination 
produced a 52% reduction in the proportion of cases of 
anaemia; the most marked improvements occurred among 
the most heavily infected children [26].
Differences in study design, monitoring indicators, 
and ancillary treatments such as iron supplements have 
contributed to conﬂ icting results in assessments of the 
outcomes of NTD programmes. Many of the populations 
living where NTDs are prevalent are iron deﬁ cient, so 
treatment which aims solely to reduce the burden of infection 
may slow the rate of iron loss but will not increase red cell 
production [20]. Published studies have suggested that 
adding iron supplements to deworming treatment may 
improve haemoglobin levels. In Sierra Leone, the addition 
of iron to anthelminthic treatment signiﬁ cantly reduced 
the fall in haemoglobin in pregnant women compared to 
anthelminthic treatment alone [27].
The impact of combining NTD treatment with iron 
supplementation is not always predictable. In children aged 
under two years in Zanzibar, iron supplements alone did 
not reduce anaemia, probably because of associated factors 
such as inﬂ ammation and malaria, whereas mebendazole 
alone induced a signiﬁ cant reduction in anaemia even in 
children with light helminth infections [28]. This ﬁ nding was 
thought to be related to the high risk of this age group for 
wasting malnutrition and for acquiring ﬁ rst time-helminth 
infections, which may induce pro-inﬂ ammatory mediators. 
In schoolchildren living in areas where hookworm infections 
are endemic, 25%–73% of occurrences of mild to severe 
anaemia and 35% of occurrences of iron deﬁ ciency are due 
Table 1. Neglected Tropical Diseases in Africa and Their Major 
Aetiological Agents
Disease Aetiological Agent
Helminth infections
Soil-transmitted infections
Hookworm infection N. americanus
Trichuriasis T. trichiura
Ascariasis Ascaris lumbricoides
Schistosomiasis
Urinary schistosomiasis S. haematobium
Hepatobiliary schistosomiasis S. mansoni, S. japonicum
Others
Lymphatic ﬁ lariasis Wuchereria bancrofti
Onchocerciasis Onchocerca volvulus
Dracunculiasis Dracunculus medinensis 
Protozoal infections
African trypanosomiasis Trypanosoma gambiense,
Trypanosoma rhodesiense
Visceral leishmaniasis (kala-azar) Leishmania donovani
Bacterial infections
Trachoma Chlamydia trachomatis
Leprosy Mycobacterium leprae
Buruli ulcer Mycobacterium ulcerans
From [1].
doi:10.1371/journal.pmed.0040231.t001
PLoS Medicine  |  www.plosmedicine.org 1287 August 2007  |  Volume 4  |  Issue 8  |  e231
to hookworm infection. Overall evidence is accumulating that 
iron supplementation should be included with anthelminthic 
therapy in NTD treatment programmes [14]. However, given 
that such supplementation may be associated with increased 
severity of infectious disease in the presence of malaria and/
or undernutrition in certain sub-groups [29], the beneﬁ ts 
need to be optimised without incurring additional risks.
Measuring Anaemia in Resource-Poor Settings
Because NTDs often co-occur with iron deﬁ ciency, treatment 
that is not combined with iron supplementation is likely to 
reduce, but not reverse, the associated fall in haemoglobin 
levels. The changes in haemoglobin level induced by 
treatment that aims only to reduce NTD infection may 
therefore not be very dramatic (see Table 2), so the method 
chosen for large-scale screening must be able to detect subtle 
changes in haemoglobin levels (Box 1).
The Haemoglobin Colour Scale (HCS) has been 
designed for ﬁ eld situations in resource-poor countries. The 
colour of a ﬁ nger prick blood sample, soaked into special 
chromatography paper, is compared with high-quality digital 
reproductions of blood of known haemoglobin concentration 
soaked into the same type of paper (Figure 1). The colours 
of the haemoglobin samples are represented in 2 g/dl 
increments from 4 g/dl to 14 g/dl. The HCS can be used by 
non-laboratory health workers after only a few hours training 
and is durable in dusty, hot, dry, and humid conditions; 
recurrent costs are less than $0.05 a test [30]. A systematic 
review suggests that the HCS is better than clinical diagnosis 
for detecting mild and moderate degrees of anaemia in 
children and pregnant women [31,32] and avoids the need 
to collect and transport venous samples [33]. Drawbacks of 
the HCS are that it requires speciﬁ c chromatography paper 
and good natural light. The HCS is too imprecise to detect 
incremental changes in haemoglobin less than 1 g/dl, and so 
its effectiveness within NTD programmes would need to be 
assessed in ﬁ eld trials.
The haemoglobin method that has been most widely used 
in ﬁ eld situations in NTD programmes (e.g., [4,13–15]) is the 
HemoCue system. This is a small battery-operated machine 
which produces a direct read-out of haemoglobin to one 
decimal place in a few seconds, using a drop of blood in a 
plastic cuvette. The HemoCue method is robust, accurate 
(correlation coefﬁ cient 0.995 in comparison to international 
reference method), and has an in-built quality checking 
mechanism. In routine practice and large ﬁ eld surveys it 
gives consistent results [34], and is very user-friendly. The 
new HemoCue Hb 301 system (Figure 2), which has been 
developed speciﬁ cally for use in tropical countries, operates 
in temperatures up to 50 °C, in dusty and humid conditions, 
and each test costs about $US0.50. Cuvettes are hygroscopic 
and need to be stored in their airtight containers.
The direct cyanmethaemoglobin method is the gold 
standard for haemoglobin measurement [35], but its use in 
surveys in remote areas is limited because it requires accurate 
dilution of the blood sample and electrical power for the 
spectrophotometer. In practice these constraints may mean 
that venous samples have to be collected, transported to a 
laboratory, and analysed retrospectively within a few hours 
[34]. To overcome these difﬁ culties, an indirect method has 
been developed in which the blood is dried on ﬁ lter paper 
for transportation and then re-dissolved in the laboratory 
for measurement. But this indirect method signiﬁ cantly 
overestimates the prevalence of anaemia, probably because 
some blood remains on the ﬁ lter paper after the dissolving 
process [34]. If the method is used for studies of anaemia 
prevalence, it can produce misleading results [36], and is 
therefore not suitable as an NTD monitoring tool.
Clinical diagnosis, the Tallqvist method, the copper 
sulphate method, and the Lovibond (undiluted) comparator 
doi:10.1371/journal.pmed.0040231.g002
Figure 2. HemoCue Hb 301
A drop of whole blood is introduced into a plastic cuvette by capillary 
action. The cuvette is placed in the machine, which produces a direct 
read-out of haemoglobin to one decimal place.
(Photo: HemoCue)
Box 1. NTD Programme Requirements for a 
Method to Measure Haemoglobin Concentrations
A test that is to be used by NTD programmes for large-scale 
monitoring and rapid scale-up should:
• be accurate enough to detect the anticipated changes in 
haemoglobin levels induced by interventions for NTDs
• not require mains electricity
• be able to be performed with minimal training and 
supervision
• use whole blood so that no dilution steps are required
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method are alternative techniques for measuring 
haemoglobin that do not require a dilution step, have been 
evaluated in primary care settings, and meet many of the 
speciﬁ cations outlined in Box 1 [37,38]. Clinical diagnosis of 
anaemia by assessment of the colour of the conjunctiva, nail 
beds, or palms is insufﬁ ciently sensitive or speciﬁ c to be used 
for monitoring changes in prevalence of mild and moderate 
anaemia [39]. Of the other techniques, only the Lovibond 
undiluted comparator may have satisfactory precision and 
accuracy [38], but it requires an exact volume of 0.03 ml of 
whole blood, which is difﬁ cult to achieve in ﬁ eld situations.
Conclusions: Next Steps for Policy and Research
Anaemia is the second most common cause of disability 
in the world [40], and is reﬂ ected in several of the global 
Millennium Development Goals [41]. The association 
between anaemia and NTD burden and control is well 
established for helminthiasis and schistosomiasis, and there 
are examples of these programmes using population changes 
in haemoglobin levels as a monitoring tool.
But iron deﬁ ciency often accompanies NTDs, so unless 
these programmes incorporate iron supplementation into 
their activities they will only be able to achieve a reduction 
in the rate of decrease of haemoglobin. Therefore the 
relationship between anaemia and the burden of other 
NTDs needs to be more clearly established before these 
programmes can reliably use anaemia as a monitoring tool 
[42].
Although anaemia could be a valuable component of an 
NTD monitoring toolkit, it should probably not be used as 
the sole indicator because confounding factors affecting the 
aetiology of anaemia, particularly dietary iron deﬁ ciency, 
will reduce its sensitivity and speciﬁ city. Drug distribution 
and compliance is therefore likely to remain the major tool 
for programme monitoring. Because anaemia is included in 
demographic health surveys, and is such an important health 
indicator in programmes for addressing major nutrition, 
malaria, and HIV, haemoglobin monitoring could be valuable 
in evaluating other disease control programmes.
Several questions must be answered before anaemia 
can be ﬁ rmly recommended as a monitoring tool for 
NTD programmes. Existing models of NTDs are generally 
considered to be cost-effective because they use minimal 
resources, but any additional activity such as haemoglobin 
Table 2. Illustrative Examples of Studies That Have Investigated the Effects of NTD Interventions on Anaemia
Location Study Population Number of 
Participants
Target 
Infection
Treatment Change (SD) in Hb (g/dl) 
Compared to Control Group
Reference
Indonesia Schoolchildren 120 T Albendazole 0 [20]
Indonesia Schoolchildren 289 T Albendazole and iron +0.56a (no additional effect from 
albendazole)
[20]
Kenya Schoolboys 36 H and/or T Albendazole +0.2 [20]
Kenya Schoolboys 53 H and/or T Albendazole +0.4a [20]
Panama Schoolchildren 116 H and T Levamisole +1.0 (±1.6)a [22]
Panama Schoolchildren 149 H Levamisole +0.1 (±1.8) [22]
Panama Schoolchildren 119 T Levamisole +0.4 (±1.8) [22]
Philippines Children and adolescents 170 S Praziquantel +0.9 (±2.2)a [43]
Philippines Children and adults 580 S Re-infection post-
praziquantel 
+0.39a [44]
Sierra Leone Pregnant women 125 H Albendazole, iron and 
folate
+2.06a [20]
South Africa Schoolchildren 179 T Albendazole, iron +0.5a (in those with low baseline 
iron)
[20]
Sri Lanka Pregnant women 195 H Mebendazole, iron and 
folate
+2.5a (controls had iron and folate 
alone)
[20]
Tanzania Schoolchildren 429 H and S Albendazole and 
praziquantel
+0.55 (±1.51)
p-value unknown
[4]
Tanzania Schoolchildren 56 H Albendazole +0.93a [25]
Tanzania Schoolchildren 79 S Praziquantel +0.46 [25]
Tanzania Schoolchildren 135 H and S Albendazole and 
praziquantel
+0.88 [25]
Tanzania Schoolchildren 357 H and/or T Albendazole and 
praziquantel
+0.24a [20]
Uganda Children 2,788 S and/or H Albendazole and 
praziquantel
+0.8a [45]
Zanzibar Children 6–72 m 459 H, T, and/or A Mebendazole and/or 
iron
+0.9 [27]
Zanzibar Schoolchildren 952 (twice yearly 
treatment);
970 (three times a year 
treatment)
H Mebendazole -1.0;+1.4 [24]
Zanzibar Schoolchildren 2,924 H and/or T Mebendazole Not signiﬁ cant [20]
astatistically signiﬁ cant (p < 0.05)
A, ascariasis; H, hookworm; S, schistosomiasis; SD, standard deviation; T, trichuriasis
doi:10.1371/journal.pmed.0040231.t002
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measurement risks over-burdening the system. Anaemia as 
a monitoring tool therefore needs to be carefully evaluated 
in pilot projects and its cost-effectiveness determined before 
planning for scale-up. The impact of NTD programmes on 
anaemia may be enhanced by careful incorporation of iron 
supplementation, but this has resource implications for 
programmes that are currently cost-effective. Data on cost-
effectiveness are available for the drug delivery components 
of integrated NTD programmes, but not for other evaluation 
components. Further studies are needed to examine the 
implications of incorporating haemoglobin measurements 
and possibly also iron supplementation into existing 
programmes.
The HemoCue system is by far the most widely used and 
accepted haemoglobin technology for NTD programme 
evaluation and is able to accurately reﬂ ect small changes in 
haemoglobin concentration. The new HemoCue Hb 301 
tropical system is also less expensive than the older Hb 201 
system. The HCS is simple and inexpensive, but it is not 
sufﬁ ciently sensitive to small changes in haemoglobin to be 
used on its own. A combination of the two systems, using 
the HCS for mass screening and the HemoCue Hb 301 
for accurate measurements and quality control, has yet to 
be evaluated but may be a reasonable approach. Rigorous 
standardisation of both methods is essential and can be 
achieved through training and regular supervision of staff.
There will inevitably be local variations in the prevalence of 
NTDs and anaemia, as well as in the availability of resources 
and technical skills to deliver and monitor NTD programmes. 
Any mechanisms for assessing the prevalence of anaemia 
should therefore be evaluated in real-life situations against 
pre-determined criteria that are derived from the overall 
objectives of the NTD programmes. Such evaluation is 
particularly important because it cannot be assumed that costs 
and effectiveness will remain constant as NTD programmes 
are scaled up and access more remote areas [26]. 
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NTD Type and Characteristics Relationship to Anaemia
Hookworm (heavy infections) Very strong
Hookworm (light infections) Strong
Trichuris (heavy infections) Strong
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